|
Market Closed -
Nasdaq
20:56:55 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 69.46 USD | +0.85% |
|
+7.22% | -15.16% |
| 08-12 | Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating | MT |
| 08-07 | Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.85% | +7.22% | +20.81% | +11.18% | -15.16% | +28.14% | +308.62% | +167.38% | - | 3.04B | |
| -0.31% | +2.44% | +20.92% | +15.07% | +4.10% | +38.43% | -0.30% | +28.60% | +90.01% | 80.23B | |
| -1.02% | -0.51% | +11.93% | +9.09% | -8.67% | -2.54% | +26.80% | +2.42% | - | 50.64B | |
| -3.10% | -4.84% | -9.93% | -10.42% | -11.02% | +10.29% | +158.34% | +116.28% | +183.60% | 46.87B | |
| -0.74% | +3.26% | +12.11% | +39.34% | -20.94% | -49.51% | -49.96% | -54.12% | +17.39% | 46.34B | |
| -0.39% | +0.91% | +6.38% | +8.75% | +19.23% | +51.39% | -22.35% | -38.69% | -33.05% | 31B | |
| -0.52% | +7.01% | -7.26% | +29.12% | +114.72% | +125.98% | -34.32% | -83.75% | - | 25.28B | |
| -0.30% | -0.33% | +4.41% | +26.07% | +21.66% | +38.24% | +83.70% | +63.55% | +49.17% | 24.36B | |
| -1.42% | -1.11% | -3.35% | +14.39% | +23.02% | -3.79% | +190.40% | +27.97% | - | 20.81B | |
| -1.83% | -2.82% | -3.42% | -0.14% | +32.33% | +60.85% | +107.54% | +149.24% | +325.10% | 16.08B | |
| -1.66% | -5.47% | -3.39% | +20.76% | +4.41% | +55.61% | +162.18% | +59.34% | - | 15.61B | |
| -1.10% | +2.95% | +41.49% | +10.62% | -9.19% | -6.59% | +781.64% | +503.25% | +6,133.38% | 15.47B | |
| -1.71% | +5.56% | +14.27% | +30.01% | +13.34% | +17.07% | -25.71% | -10.22% | -27.66% | 13.04B | |
| -0.14% | +0.30% | -10.17% | -6.30% | +16.83% | +95.37% | +199.01% | +833.40% | +2,943.87% | 11.19B | |
| +1.20% | +1.78% | -5.13% | +8.48% | +34.77% | +121.12% | +172.44% | +491.44% | - | 9.83B | |
| -5.36% | +2.51% | +28.03% | +141.14% | +273.80% | +321.66% | +455.10% | +17.97% | - | 7.44B | |
| -2.86% | -3.10% | +9.31% | +8.45% | -7.85% | -21.09% | -26.91% | -52.11% | -50.21% | 6.86B | |
| -3.23% | +7.59% | +7.59% | +32.61% | +10.15% | +19.97% | +76.51% | -0.69% | - | 6.62B | |
| +1.72% | +3.09% | -10.00% | +5.41% | +17.81% | +35.14% | +274.29% | +248.81% | - | 6.43B | |
| -1.39% | +0.91% | +24.41% | +35.82% | +86.06% | +129.93% | +362.35% | +527.04% | - | 5.99B | |
| Average | -1.17% | +1.75% | +7.45% | +21.47% | +29.97% | +53.28% | +159.97% | +149.85% | +963.16% | 22.16B | |
| Weighted average by Cap. | -1.08% | +1.03% | +7.79% | +16.80% | +15.10% | +32.65% | +88.90% | +77.51% | +511.75% |
- Stock Market
- Stocks
- TARS Stock
- Sector Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
